This remarkable range of motion comes at a cost: vulnerability to injury and notoriously slow healing times
Clearance occurs primarily via enzymatic degradation by serum and tissue peptidases
They have unique advantages in targeted delivery, controlled release, and in situ therapy for conditions such as peptic ulcers, inflammatory bowel disease (IBD), colorectal cancer (CRC), diabetes, and pancreatic cancer (PC)
Useful safety observations often include: Local tolerance: redness, irritation, swelling, or tenderness at the administration site Acute post-dose observations: changes in behavior, appetite, activity, or visible discomfort during the expected response window Pattern effects over time: whether repeated dosing appears to change tolerability or response consistency Protocol drift: missed timing windows, inconsistent preparation, or undocumented deviations that can confuse safety interpretation How dosing logic affects safety interpretation The why behind dosage matters most
Research continues to refine techniques, improve outcomes, and expand applications
Basically, it tells certain genes to turn on or off, encouraging your cells to regenerate and heal faster